Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

64.73 -0.12 (-0.19%)

Streaming Delayed Price Updated: 11:23 AM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9

...

91 92 Next >

Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Growth portfolio now drives 60% of revenue as Eliquis surges 21%.

Via The Motley Fool

Topics Earnings

Why Bristol Myers Squibb Stock Topped the Market on Thursday ↗

July 30, 2026

It notched convincing beats on analyst estimates with its second-quarter performance.

Via The Motley Fool

Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About ↗

July 30, 2026

Things are going well for the pharmaceutical giant.

Via The Motley Fool

Topics Lawsuit

Bristol-Myers Squibb (NYSE:BMY) Surges on Q2 Earnings Beat, Raises Full-Year Guidance ↗

July 30, 2026

Via Chartmill

Topics Earnings

Bristol Myers Squibb Co (NYSE:BMY): A High Yield Dividend Stock Backed by Strong Profitability ↗

July 18, 2026

Via Chartmill

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Play with Cautionary Notes ↗

June 26, 2026

Via Chartmill

Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

July 30, 2026

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.7% year on ...

Via StockStory

Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

July 30, 2026

From Bristol Myers Squibb

Via Business Wire

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

July 28, 2026

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday before market open. Here’s what to look for. Bristol-Myers ...

Via StockStory

This Healthcare Leader Just Made a Bet on Artificial Intelligence (AI): Time to Buy the Stock? ↗

July 28, 2026

Bristol Myers keeps making moves to establish a strong foundation for the future.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

My 3 Favorite Artificial Intelligence (AI) Stocks to Buy Right Now ↗

July 28, 2026

We may still be in the early innings of the AI revolution, and these companies could be among the biggest winners.

Via The Motley Fool

Topics Artificial Intelligence Electric Vehicles

Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now ↗

July 27, 2026

As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal.

Via MarketBeat

Topics Economy

Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't? ↗

July 26, 2026

Analysts aren't nearly as bullish about Bristol Myers Squibb as this billionaire hedge fund manager is.

Via The Motley Fool

Topics Intellectual Property

Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer ↗

July 24, 2026

Sometimes you need to look beyond the numbers to get the full story.

Via The Motley Fool

Topics Intellectual Property

3 Healthcare Stocks We Keep Off Our Radar

July 24, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Via StockStory

BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring ↗

July 23, 2026

Could it become as successful in this niche as it was in the coronavirus vaccine market?

Via The Motley Fool

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

July 20, 2026

From Bristol Myers Squibb

Via Business Wire

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb ↗

July 14, 2026

Drug pricing matters, but pipelines matter even more.

Via The Motley Fool

Topics Government Intellectual Property

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

July 13, 2026

From Bristol Myers Squibb

Via Business Wire

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗

July 07, 2026

They may not remain cheap for too much longer.

Via The Motley Fool

Topics Intellectual Property

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) ↗

July 07, 2026

It doesn't get much more dependable and lucrative than the healthcare industry.

Via The Motley Fool

Topics Intellectual Property

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know. ↗

July 06, 2026

This big pharma stock looks attractive for income investors -- but it comes with some risk.

Via The Motley Fool

Topics Intellectual Property

Vanguard Is Bullish on Value Stocks and Fixed Income. Are These 2 ETFs a Good Buy? ↗

July 05, 2026

Strong productivity gains from AI -- and lower inflation -- could be good news for these Vanguard ETFs.

Via The Motley Fool

Topics Artificial Intelligence Bonds ETFs

2 Cash-Producing Stocks Worth Investigating and 1 Facing Headwinds

July 03, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 01, 2026

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How do their financials and risks stack up?

Via The Motley Fool

Rolling Into Spreads: Extend Profit Potential with Lower Risk ↗

June 30, 2026

Learn how a vertical spread options strategy can help reduce risk, lock in gains, and stay invested in winning trades.

Via InvestorPlace

June 30, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Via StockStory

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 26, 2026

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.

Via The Motley Fool

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

June 24, 2026

Via Investor Brand Network

The Quest to Repair What Multiple Sclerosis Takes Away

June 24, 2026

From BioMedWire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

91 92 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.